⌘K

Login Start Free

Home/Filings/4/0001209191-23-002566

4//SEC Filing

Tarriff Scott 4

Accession 0001209191-23-002566

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:33 PM ET

Size

4.8 KB

Accession

0001209191-23-002566

Insider Transaction Report

Form 4

Period: 2023-01-05

EAGLE PHARMACEUTICALS, INC.EGRX

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2023-01-05$29.26/sh−3,827$111,978→ 1,575,879 total

Footnotes (1)

[F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001469124

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 4:33 PM ET
Size: 4.8 KB

View on SEC.gov